At the end of September 2013, the EMCDDA and Europol examined the available information on a new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2- methoxybenzyl)phenethylamine, commonly known by the abbreviation ‘25I-NBOMe’, through a joint assessment based upon the following criteria:
1. the amount of the material seized;
2. evidence of organised crime involvement;
3. evidence of international trafficking;
4. analogy with better-studied compounds;
5. evidence of the potential for further (rapid) spread; and,
6. evidence of cases of serious intoxication or fatalities.
The EMCDDA and Europol agreed that the information collected on 25I-NBOMe satisfied criteria 1, 3, 5 and 6. The two organisations therefore concluded that sufficient information had been accumulated to merit the production of a Joint Report
on 25I-NBOMe as stipulated by Article 5.1 of the Decision.